Active Ingredient Purpose

Manufacturer
Texas MiratiFul Enterprises Inc. | Private Label Partners, Inc.
Effective date
2026-08-03
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
daily-update
Hydrated at
2026-08-06 06:10:16

Label at a glance#

ProductMiratiFul Nail Fungus Treatment
Active ingredientTOLNAFTATE
Label structure6 sections

Indications and uses

Effective treatment of athlete’s foot, jock itch, and ringworm. Not for the relief of infected fingernails and toenails or effective against bacteria or viruses.

Dosage and administration

▪ Clean or wash the affected area and dry thoroughly. Apply a thin layer of the product over the affected area twice daily (morning and night) or as directed by a doctor. Supervise children in the use of this product. For athelete’s foot: Pay special attention to spaces between toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. For athlete’s foot and ringworm, use daily for ...

Label contents#

Full prescribing information#

Active Ingredient             Purpose

OTC - ACTIVE INGREDIENT SECTION


Tolnaftate 1%                Antifungal

Uses

INDICATIONS & USAGE SECTION

  • Effective treatment of athlete’s foot, jock itch, and ringworm.
  • Not for the relief of infected fingernails and toenails or effective against bacteria or viruses.

Warnings

WARNINGS SECTION

▪ For external use only.
▪ Avoid contact with the eyes.
▪ Do not use on children under 2 years of age unless directed by a doctor.
▪ Keep this and all drugs out of the reach of children.
▪ If treating athlete’s foot and ringworm: If irritation occurs or if there is no improvement within 4 weeks, discontinue use and consult a doctor.
▪ If treating jock itch: If irritation occurs or if there is no improvement within 2 weeks, discontinue use and consult a doctor.
▪ If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

▪ Clean or wash the affected area and dry thoroughly. Apply a thin layer of the product over the affected area twice daily (morning and night) or as directed by a doctor. Supervise children in the use of this product. For athelete’s foot: Pay special attention to spaces between toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. For athlete’s foot and ringworm, use daily for 4 weeks; for jock itch, use daily for 2 weeks. If condition persists longer, consult a doctor. This product is not effective on the scalp or nails.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Prunus amygdalus dulcis (Sweet almond) oil, Cymbopogan nardus (Citronella) oil, Lavandula augustifolia (Lavender) oil, Melaleuca alternifolia (Tea tree) oil, Simmondsia chinensis (Jojoba) oil, Syzyglum aromaticum (Clovebud) oil, Azadirachta indica (Neem) oil, Tocopheryl acetate (Vitamin E)

Product label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage descriptionimage descriptionimage description

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87885-00187885-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MiratiFul Nail Fungus TreatmentTOLNAFTATETexas MiratiFul Enterprises Inc.35eb20e3-86d4-4bec-b572-3d5fe86ac74d2026-08-03WarningsExact identifier
ndc (package): 87885-001-01
ndc (product): 87885-001
ndc11 (package): 87885000101
spl id: 58295d84-4d47-3613-e063-6394a90a1fd6
spl set id: 35eb20e3-86d4-4bec-b572-3d5fe86ac74d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.